[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Universe Pharmaceuticals Inc (UPC)

Universe Pharmaceuticals Inc (UPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Universe Pharmaceuticals INC is a pharmaceutical producer and distributor principally in China. The Company specializes in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the aging process. It also distributes and sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Universe Pharmaceuticals INC is headquartered in Ji'an, Jiangxi, China.

Fiscal Year End Date: 09/30

(Values in U.S. Thousands) Mar, 2025 Sep, 2024 Mar, 2024 Sep, 2023 Mar, 2023
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income 0 0 0 0 0
Net Income Growth unch unch unch unch unch
(Values in U.S. Thousands) Mar, 2025 Sep, 2024 Mar, 2024 Sep, 2023 Mar, 2023
Total Assets 69,300 80,670 67,950 49,430 53,290
Total Assets Growth -14.09% +18.72% +37.47% -7.24% -24.27%
Total Liabilities 13,170 25,480 22,450 22,690 13,750
Total Liabilities Growth -48.31% +13.50% -1.06% +65.02% -40.83%
(Values in U.S. Thousands) Mar, 2025 Sep, 2024 Mar, 2024 Sep, 2023 Mar, 2023
Operating Cash Flow -5,050 2,560 -9,510 -2,430 1,120
Operating Cash Flow Growth -297.27% +126.92% -291.36% -316.96% -76.67%
Net Cash Flow 4,090 17,780 24,210 3,580 -430
Change in Net Cash Flow -77.00% -26.56% +576.26% +932.56% -105.94%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.